Skip to main content
Clinical Trials/ChiCTR2200060517
ChiCTR2200060517CompletedUnknown

Silodosin as a Medical Expulsive Therapy for Distal Ureteral Stones in the Pakistani Population

Not provided1 site in 1 countryStarted: May 16, 2021Last updated:

Trial Snapshot

Phase
Unknown
Status
Completed
Locations
1
Primary Endpoint
Stone Free Rate

Study Overview

Brief Summary

we aim to determine the efficacy of silodosin drug for treatment of distal ureteric stones.

Study Design

Study Type
Interventional
Primary Purpose
单臂
Masking
None

Eligibility Criteria

Ages
19 to 76 (—)
Sex
All

Inclusion Criteria

  • All the patients regardless of gender coming to urology outpatient department of KRL hospital with distal ureteric stone of 10mm as confirmed by ultrasonography kidney ureter bladder were included in our study.

Exclusion Criteria

  • Patients previously taking any medication or any other invasive procedure were excluded from our study. Patients with pyelonephritis, fever, Interactable pain or having creatinine deranged were also excluded from our study.

Arms & Interventions

Case series

Outcomes

Primary Outcomes

Stone Free Rate

Time Frame: stone expulsion after how many days

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Not provided

Study Sites (1)

Loading locations...

Similar Trials